Overview: Advanced Big data courses equip learners with skills in analytics, machine learning, and data visualization.Hands-on experience with tools like Hadoop ...
SANTA CLARA, CA - December 16, 2025 - - As artificial intelligence tools become deeply embedded in modern software development workflows, a counterintuitive shift is taking shape across the technology ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
AI is now a core part of business strategy, and leaders who understand how to use it can make faster decisions, drive ...
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
The seventh installment in a series recapping key sessions from the Data Center Frontier Trends Summit 2025 (Aug. 26–28) in ...
This year not only stretched our industry, but exposed our fault lines.
Neural Concept aims to accelerate these timelines by integrating AI directly into CAD and physics-based simulation environments. With its software, teams can explore numerous design specifications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback